A systemic review of taxanes and their side effects in metastatic breast cancer
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A systemic review of taxanes and their side effects in metastatic breast cancer
Authors
Keywords
-
Journal
Frontiers in Oncology
Volume 12, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2022-10-11
DOI
10.3389/fonc.2022.940239
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Persistent taxane‐induced neuropathy in elderly patients treated for localized breast cancer
- (2020) Lucile Pabst et al. Breast Journal
- Preliminary safety and efficacy of first-line pertuzumab combined with trastuzumab and taxane therapy for HER2-positive locally recurrent or metastatic breast cancer (PERUSE)
- (2019) T Bachelot et al. ANNALS OF ONCOLOGY
- Patient‐reported and clinician‐reported chemotherapy‐induced peripheral neuropathy in patients with early breast cancer: Current clinical practice
- (2019) Kirsten A. Nyrop et al. CANCER
- Tumor-Associated Neutrophils in Cancer: Going Pro
- (2019) Wu et al. Cancers
- Chemotherapy-Induced Neutropenia as a Prognostic and Predictive Marker of Outcomes in Solid-Tumor Patients
- (2018) Pashtoon Murtaza Kasi et al. DRUGS
- Timing of chemotherapy-induced neutropenia: the prognostic factor in advanced pancreatic cancer patients treated with gemcitabine / gemcitabine-based chemotherapy
- (2017) Yang Chen et al. Oncotarget
- Incidence and Mortality and Epidemiology of Breast Cancer in the World
- (2016) Mahshid Ghoncheh et al. Asian Pacific Journal of Cancer Prevention
- Severe neutropenia during cabazitaxel treatment is associated with survival benefit in men with metastatic castration-resistant prostate cancer (mCRPC): A post-hoc analysis of the TROPIC phase III trial
- (2016) Alexander Meisel et al. EUROPEAN JOURNAL OF CANCER
- Exploring patient- and physician-related factors preventing breast cancer patients from guideline-adherent adjuvant chemotherapy—results from the prospective multi-center study BRENDA II
- (2016) Lukas Schwentner et al. SUPPORTIVE CARE IN CANCER
- Pertuzumab, Trastuzumab, and Docetaxel in HER2-Positive Metastatic Breast Cancer
- (2015) Sandra M. Swain et al. NEW ENGLAND JOURNAL OF MEDICINE
- Taxanes enhance trastuzumab-mediated ADCC on tumor cells through NKG2D-mediated NK cell recognition
- (2015) Martina Di Modica et al. Oncotarget
- Management of prostate cancer in older patients: updated recommendations of a working group of the International Society of Geriatric Oncology
- (2014) Jean-Pierre Droz et al. LANCET ONCOLOGY
- Awareness of the adverse effects associated with prophylactic corticosteroid use during docetaxel therapy
- (2014) Ka-Eun Yoo et al. SUPPORTIVE CARE IN CANCER
- Presentation and management of docetaxel-related adverse effects in patients with breast cancer
- (2014) Maria Ho et al. Cancer Management and Research
- Definitive Results of a Phase III Adjuvant Trial Comparing Three Chemotherapy Regimens in Women With Operable, Node-Positive Breast Cancer: The NSABP B-38 Trial
- (2013) Sandra M. Swain et al. JOURNAL OF CLINICAL ONCOLOGY
- 2-weekly versus 3-weekly docetaxel to treat castration-resistant advanced prostate cancer: a randomised, phase 3 trial
- (2013) Pirkko-Liisa Kellokumpu-Lehtinen et al. LANCET ONCOLOGY
- Hypersensitivity reaction studies of a polyethoxylated castor oil-free, liposome-based alternative paclitaxel formulation
- (2013) HONGBO WANG et al. Molecular Medicine Reports
- Phase III Trial Evaluating Weekly Paclitaxel Versus Docetaxel in Combination With Capecitabine in Operable Breast Cancer
- (2012) Catherine M. Kelly et al. JOURNAL OF CLINICAL ONCOLOGY
- Cimetidine enhances delayed-type hypersensitivity responses and serum interleukin (IL)-2, -10, -12, and IL-17 levels after burn injury in an animal model
- (2012) A. Jafarzadeh et al. Journal of Immunotoxicology
- Weekly docetaxel in metastatic breast cancer patients: No superior benefits compared to three-weekly docetaxel
- (2011) Carolien P. Schröder et al. EUROPEAN JOURNAL OF CANCER
- Complement activation by polyethoxylated pharmaceutical surfactants: Cremophor-EL, Tween-80 and Tween-20
- (2011) Zsóka Weiszhár et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Prospective Multicenter Randomized Phase III Study of Weekly versus Standard Docetaxel (D2) for First-Line Treatment of Metastatic Breast Cancer
- (2011) Hans-Joachim Stemmler et al. ONCOLOGY
- Intravenous therapies for castration-resistant prostate cancer: Toxicities and adverse events
- (2011) Eric A. Singer et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Dexamethasone premedication for prophylaxis of taxane toxicities: Can the doses be reduced when paclitaxel or docetaxel are given weekly?
- (2011) Joanna R Schwartz JOURNAL OF ONCOLOGY PHARMACY PRACTICE
- Meta-analysis of neutropenia or leukopenia as a prognostic factor in patients with malignant disease undergoing chemotherapy
- (2010) Kohei Shitara et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Longer Therapy, Iatrogenic Amenorrhea, and Survival in Early Breast Cancer
- (2010) Sandra M. Swain et al. NEW ENGLAND JOURNAL OF MEDICINE
- Single premedication dose of dexamethasone 20 mg IV before docetaxel administration
- (2010) Jyoti D Chouhan et al. JOURNAL OF ONCOLOGY PHARMACY PRACTICE
- Phase 3 study comparing the use of docetaxel on an every-3-week versus weekly schedule in the treatment of metastatic breast cancer
- (2008) Edgardo Rivera et al. CANCER
- Gemcitabine Plus Paclitaxel Versus Paclitaxel Monotherapy in Patients With Metastatic Breast Cancer and Prior Anthracycline Treatment
- (2008) Kathy S. Albain et al. JOURNAL OF CLINICAL ONCOLOGY
- Randomized Phase III Trial of Weekly Compared With Every-3-Weeks Paclitaxel for Metastatic Breast Cancer, With Trastuzumab for all HER-2 Overexpressors and Random Assignment to Trastuzumab or Not in HER-2 Nonoverexpressors: Final Results of Cancer and Leukemia Group B Protocol 9840
- (2008) Andrew D. Seidman et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II Trial of Weekly Dose-Dense Paclitaxel in Extensive-Stage Small Cell Lung Cancer: Cancer and Leukemia Group B Study 39901
- (2008) Stephen L. Graziano et al. Journal of Thoracic Oncology
- Weekly Paclitaxel in the Adjuvant Treatment of Breast Cancer
- (2008) Joseph A. Sparano et al. NEW ENGLAND JOURNAL OF MEDICINE
- Taxane-Based Combinations As Adjuvant Chemotherapy of Early Breast Cancer: A Meta-Analysis of Randomized Trials
- (2007) Michele De Laurentiis et al. JOURNAL OF CLINICAL ONCOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now